A Study of GensSci098 in Subjects With Graves' Disease

NCT07286656 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
GenSci098
Graves Disease

Interventions

DRUG: GenSci098

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.